Adiponectin and Interleukin-6 in Inflammation-Associated Disease

Vitamins and Hormones

Volumn 90, Issue , 2012, Pages 375-395

  Li, Li ^a   Wu, Li Ling ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Adiponectin; Autoimmune diseases; Cardiovascular disease; Inflammation; Interleukin 6; Obesity; Type 2 diabetes

Indexed keywords

EID: 84866616241     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-398313-8.00014-2     Document Type: Chapter

References (99)

1. Ajuwon K.M., Spurlock M.E. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2005, 288:R1220-R1225.
2. Arita Y., Kihara S., Ouchi N., Maeda K., Kuriyama H., Okamoto Y., et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cells. Circulation 2002, 105:2893-2898.
3. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999, 257:79-83.
4. Aso Y., Yamamoto R., Wakabayashi S., Uchida T., Takayanagi K., Takebayashi K., et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006, 55:1954-1960.
5. Awazawa M., Ueki K., Inabe K., Yamauchi T., Kubota N., Kaneko K., et al. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metabolism 2011, 13:401-412.
6. Banerjee I., Fuseler J.W., Intwala A.R., Baudino T.A. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart. American Journal of Physiology. Heart and Circulatory Physiology 2009, 296:H1694-H1704.
7. Berg A.H., Combs T.P., Du X.L., Brownlee M., Scherer P. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 2001, 7:947-953.
8. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circulation Research 2005, 96:939-949.
9. Blüher M., Brennan A.M., Kelesidis T., Kratzsch J., Fasshauer M., Kralisch S., et al. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: Comparative evaluation of three assays. Diabetes Care 2007, 30:280-285.
10. Ceddia R.B., Somwar R., Maida A., Fang X., Bikopoulos G., Sweeney G. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 2005, 48:132-139.
11. Charles B.A., Doumatey A., Huang H., Zhou J., Chen G., Shriner D., et al. The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans. The Journal of Clinical Endocrinology and Metabolism 2011, 96:E2018-E2022.
12. Chen H., Montagnani M., Funahashi T., Shimomura I., Quon M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. The Journal of Biological Chemistry 2003, 278:45021-45026.
13. Chen M.P., Tsai J.C., Chung F.M., Yang S.S., Hsing L.L., Shin S.J., et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25:821-826.
14. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
15. Combs T.P., Berg A.H., Obici S., Scherer P.E., Rossetti L. Endogenous glucose production is inhibited by the adipose derived protein Acrp30. The Journal of Clinical Investigation 2001, 108:1875-1881.
16. Di Gregorio G.B., Hensley L., Lu T., Ranganathan G., Kern P.A. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: Absence of development of age-related obesity. American Journal of Physiology. Endocrinology and Metabolism 2004, 287:E182-E187.
17. Diaz J.A., Booth A.J., Lu G., Wood S.C., Pinsky D.J., Bishop D.K. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. American Journal of Transplantation 2009, 9:1773-1783.
18. Ding M., Carrão A.C., Wagner R.J., Xie Y., Jin Y., Rzucidlo E.M., et al. Vascular smooth muscle cell-derived adiponectin: A paracrine regulator of contractile phenotype. Journal of Molecular and Cellular Cardiology 2012, 52:474-484.
19. Ehling A., Schäffler A., Herfarth H., Tarner I.H., Anders S., Distler O., et al. The potential of adiponectin in driving arthritis. Journal of Immunology 2006, 176:4468-4478.
20. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145:2273-2282.
21. Fan D., Li L., Wang C., Cui X.B., Zhou Y., Wu L.L. Adiponectin induces interleukin-6 production and its underlying mechanism in adult rat cardiac fibroblasts. Journal of Cellular Physiology 2011, 226:1793-1802.
22. Fantuzzi G. Adiponectin and inflammation: Consensus and controversy. The Journal of Allergy and Clinical Immunology 2008, 121:326-330.
23. Fasshauer M., Kralisch S., Klier M., Lossner U., Bluher M., Klein J., et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2003, 301:1045-1050.
24. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R.S., Yen F.T., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:2005-2010.
25. Furuta M., Tamai M., Hanabusa T., Yamamoto Y., Nanjo K., Sanke T. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients. Diabetes Research and Clinical Practice 2006, 72:302-307.
26. Gualillo O., González-Juanatey J.R., Lago F. The emerging role of adipokines as mediators of cardiovascular function: Physiologic and clinical perspectives. Trends in Cardiovascular Medicine 2007, 17:275-283.
27. Hada Y., Yamauchi T., Waki H., Tsuchida A., Hara K., Yago H., et al. Selective purification and characterization of adiponectin multimer species from human plasma. Biochemical and Biophysical Research Communications 2007, 356:487-493.
28. Haugen F., Drevon C.A. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 2007, 148:5478-5486.
29. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 2000, 20:1595-1599.
30. Hotta K., Funahashi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansen B.C., et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126-1133.
31. Hu E., Liang P., Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. The Journal of Biological Chemistry 1996, 271:10697-10703.
32. Hug C., Wang J., Ahmad N.S., Bogan J.S., Tsao T.S., Lodish H.F. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:10308-10313.
33. Iglseder B., Mackevics V., Stadlmayer A., Tasch G., Ladurner G., Paulweber B. Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: Data from the SAPHIR Study. Stroke 2005, 36:2577-2582.
34. Iwabu M., Yamauchi T., Okada-Iwabu M., Sato K., Nakagawa T., Funata M., et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca2+ and AMPK/SIRT1. Nature 2010, 464:1313-1319.
35. Iwashima Y., Horio T., Suzuki Y., Kihara S., Rakugi H., Kangawa K., et al. Adiponectin and inflammatory markers in peripheral arterial occlusive disease. Atherosclerosis 2006, 188:384-390.
36. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004, 43:1318-1323.
37. Katsiougiannis S., Tenta R., Skopouli F.N. Activation of AMP-activated protein kinase by adiponectin rescues salivary gland epithelial cells from spontaneous and interferon-γ-induced apoptosis. Arthritis and Rheumatism 2010, 62:414-419.
38. Kelly M., Ruderman N.B., Tomas E. AMP-activated protein kinase and its regulation by adiponectin and interleukin-6. The Scandinavian Journal of Food and Nutrition 2006, 50(Suppl. 2):85-91.
39. Klover P.J., Clementi A.H., Mooney R.A. Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 2005, 146:3417-3427.
40. Klover P.J., Zimmers T.A., Koniaris L.G., Mooney R.A. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003, 52:2784-2789.
41. Kollias A., Tsiotra P.C., Ikonomidis I., Maratou E., Mitrou P., Kyriazi E., et al. Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease. Cardiovascular Diabetology 2011, 10:14.
42. Kubaszek A., Pihlajamäki J., Punnonen K., Karhapää P., Vauhkonen I., Laakso M. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 2003, 52:558-561.
43. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 23:85-89.
44. Lago F., Dieguez C., Gómez-Reino J., Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nature Clinical Practice. Rheumatology 2007, 3:716-724.
45. Lago F., Dieguez C., Gómez-Reino J., Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine & Growth Factor Reviews 2007, 18:313-325.
46. Lara-Castro C., Luo N., Wallace P., Klein R.L., Garvey W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2003, 55:249-259.
47. Li L., Zhang K., Cai X.J., Feng M., Zhang Y., Zhang M. Adiponectin upregulates prolyl-4-hydroxylase α1 expression in interleukin 6-stimulated human aortic smooth muscle cells by regulating ERK 1/2 and Sp1. PloS One 2011, 6:e22819.
48. Liao W., Yu C., Wen J., Jia W., Li G., Ke Y., et al. Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts. Biology of the Cell 2009, 101:263-272.
49. Lira F.S., Rosa J.C., Dos Santos R.V., Venancio D.P., Carnier J., Sanches P.de.L., et al. Visceral fat decreased by long-term interdisciplinary lifestyle therapy correlated positively with interleukin-6 and tumor necrosis factor-α and negatively with adiponectin levels in obese adolescents. Metabolism 2011, 60:359-365.
50. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 2002, 8:731-737.
51. Matsuda M., Shimomura I., Sata M., Arita Y., Nishida M., Maeda N. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. The Journal of Biological Chemistry 2002, 277:37487-37491.
52. Matsushita K., Iwanaga S., Oda T., Kimura K., Shimada M., Sano M., et al. Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis. Laboratory Investigation 2005, 85:1210-1223.
53. Moschen A.R., Molnar C., Geiger S., Graziadei I., Ebenbichler C.F., Weiss H., et al. Anti-inflammatory effects of excessive weight loss: Potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut 2010, 59:1259-1264.
54. Nakamura Y., Shimada K., Fukuda D., Shimada Y., Ehara S., Hirose M., et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004, 90:528-533.
55. Nakano Y., Tobe T., ChoiMiura N.H., Mazda T., Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. Journal of Biochemistry 1996, 120:803-812.
56. Nayak B.S., Ramsingh D., Gooding S., Legall G., Bissram S., Mohammed A., et al. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians. Primary Care Diabetes 2010, 4:187-192.
57. Neumeier M., Weigert J., Schäffler A., Wehrwein G., Müller-Ladner U., Schölmerich J. Different effects of adiponectin isoforms in human monocytic cells. Journal of Leukocyte Biology 2006, 79:803-808.
58. Ogunwobi O.O., Beales I.L. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regulatory Peptides 2006, 134:105-113.
59. Okamoto Y., Kihara S., Ouchi N., Nishida M., Arita Y., Kumada M., et al. Adiponectin reduces atherosclerosis in apolipoprotein E deficient mice. Circulation 2002, 106:2767-2770.
60. Otero M., Lago R., Gomez R., Lago F., Dieguez C., Gómez-Reino J.J., et al. Changes in fat-derived hormones plasma concentrations: Adiponectin, leptin, resistin and visfatin in rheumatoid arthritis subjects. Annals of the Rheumatic Diseases 2006, 65:1198-1201.
61. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
62. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001, 103:1057-1063.
63. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation 2000, 102:1296-1301.
64. Ouchi N., Kobayashi H., Kihara S., Kumada M., Sato K., Inoue T., et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. The Journal of Biological Chemistry 2004, 279:1304-1309.
65. Ouchi N., Walsh K. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 2007, 380:24-30.
66. Pääkkö T., Ukkola O., Ikäheimo M., Kesäniemi Y.A. Plasma adiponectin levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects. Annals of Medicine 2010, 43:131-137.
67. Pedersen B.K., Febbraio M.A. Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiological Reviews 2008, 88:1379-1406.
68. Perseghin G., Lattuada G., Danna M., Sereni L.P., Maffi P., De Cobelli F., et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. American Journal of Physiology. Endocrinology and Metabolism 2003, 285:E1174-E1181.
69. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA: The Journal of the American Medical Association 2004, 291:1730-1737.
70. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA: The Journal of the American Medical Association 2001, 286:327-334.
71. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., et al. Adiponectin as a biomarker of the metabolic syndrome. Circulation Journal 2004, 68:975-981.
72. Sada K.E., Yamasaki Y., Maruyama M., Sugiyama H., Yamamura M., Maeshima Y., et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. The Journal of Rheumatology 2006, 33:1545-1552.
73. Saito K., Tobe T., Minoshima S., Asakawa S., Sumiya J., Yoda M., et al. Organization of the gene for gelatin binding protein (GBP) 28. Gene 1999, 229:67-73.
74. Schäffler A., Ehling A., Neumann E., Herfarth H., Tarner I., Schölmerich J., et al. Adipocytokines in synovial fluid. JAMA: The Journal of the American Medical Association 2003, 290:1709-1710.
75. Scherer P.E., Williams S., Fegliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q produced exclusively in adipocytes. The Journal of Biological Chemistry 1995, 270:26746-26747.
76. Schulze M.B., Shai I., Rimm E.B., Li T., Rifai N., Hu F.B. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 2005, 54:534-539.
77. Senn J.J., Klover P.J., Nowak I.A., Zimmers T.A., Koniaris L.G., Furlanetto R.W., et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. The Journal of Biological Chemistry 2003, 278:13740-13746.
78. Senolt L., Pavelka K., Housa D., Haluzík M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 2006, 35:247-252.
79. Shapiro L., Scherer P.E. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology 1998, 8:335-340.
80. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nature Medicine 2005, 11:1096-1103.
81. Smart N., Mojet M.H., Latchman D.S., Marber M.S., Duchen M.R., Heads R.J. IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. Cardiovascular Research 2006, 69:164-177.
82. Snehalatha C., Mukesh B., Simon M., Viswanathan V., Haffner S.M., Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003, 26:3226-3229.
83. Stith R.D., Luo J. Endocrine and carbohydrate responses to interleukin-6 in vivo. Circulatory Shock 1994, 44:210-215.
84. Takemura Y., Ouchi N., Shibata R., Aprahamian T., Kirber M.T., Summer R.S., et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. The Journal of Clinical Investigation 2007, 117:375-386.
85. Tang C.H., Chiu Y.C., Tan T.W., Yang R.S., Fu W.M. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. Journal of Immunology 2007, 179:5483-5492.
86. Tomas E., Tsao T.S., Saha A.K., Murrey H.E., Zhang C.C., Itani S.I., et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:16309-16313.
87. Toussirot E., Gaugler B., Bouhaddi M., Nguyen N.U., Saas P., Dumoulin G. Elevated adiponectin serum levels in women with systemic autoimmune diseases. Mediators of Inflammation 2010, 2010:938408.
88. Tsatsanis C., Zacharioudaki V., Androulidaki A., Dermitzaki E., Charalampopoulos I., Minas V., et al. Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochemical and Biophysical Research Communications 2005, 335:1254-1263.
89. Tsutamoto T., Hisanaga T., Wada A., Maeda K., Ohnishi M., Fukai D., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. Journal of the American College of Cardiology 1998, 31:391-398.
90. Vozarova B., Weyer C., Hanson K., Tataranni P.A., Bogardus C., Pratley R.E. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Research 2001, 9:414-417.
91. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. The Journal of Clinical Investigation 2003, 112:1785-1788.
92. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. The Journal of Clinical Endocrinology and Metabolism 2001, 86:1930-1935.
93. Wolf A.M., Wolf D., Rumpold H., Enrich B., Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochemical and Biophysical Research Communications 2004, 323:630-635.
94. Wu X.D., Motoshima H., Mahadev K., Stalker T.J., Scalia R., Goldstein B.J. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocyte. Diabetes 2003, 52:1355-1363.
95. Wulster-Radcliffe M.C., Ajuwon K.M., Wang J., Christian J.A., Spurlock M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochemical and Biophysical Research Communications 2004, 316:924-929.
96. Yamamoto Y., Hirose H., Saito I., Nishikai K., Saruta T. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: Two-year follow-up study in Japanese population. The Journal of Clinical Endocrinology and Metabolism 2004, 89:87-90.
97. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature Medicine 2003, 423:762-769.
98. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE deficient mice from atherosclerosis. The Journal of Biological Chemistry 2003, 278:2461-2468.
99. Yamauchin T., Kamon J., Waki H. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001, 7:941-956.